CA
DXCM icon

CoreCap Advisors’s DexCom DXCM Stock Holding History

CoreCap Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.3K Sell
613
-1
-0.2% -$67 ﹤0.01% 1486
2026
Q1 		$38.6K Buy
614
+23
+4% +$1.6K ﹤0.01% 1415
2025
Q4 		$39.2K Sell
591
-436
-42% -$28.2K ﹤0.01% 1422
2025
Q3 		$69.1K Sell
1,027
-2
-0.2% -$158 ﹤0.01% 1182
2025
Q2 		$89.8K Sell
1,029
-81
-7% -$6.35K ﹤0.01% 1025
2025
Q1 		$75.8K Buy
1,110
+353
+47% +$28.8K ﹤0.01% 1002
2024
Q4 		$58.9K Sell
757
-76
-9% -$5.63K ﹤0.01% 1118
2024
Q3 		$55.8K Buy
+833
New +$68.4K ﹤0.01% 1139
2024
Q2 		– Sell
-348
Closed -$48.3K – 1858
2024
Q1 		$48.3K Buy
+348
New +$43.7K ﹤0.01% 1131
2022
Q4 		$34.9K Buy
+308
New +$33.8K ﹤0.01% 1106
2022
Q3 		– Sell
-240
Closed -$18K – 932
2022
Q2 		$18K Buy
+240
New +$21.9K ﹤0.01% 1274
2022
Q1 		– Sell
-6,744
Closed -$905K – 939
2021
Q4 		$905K Buy
+6,744
New +$969K 0.06% 255

Other funds holding DXCM

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

CoreCap Advisors's DXCM Position: Q2 2026 in Review

CoreCap Advisors reduced its DexCom (DXCM) stake by 0.16% in Q2 2026, selling an estimated $67 and leaving 613 shares worth $41.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

CoreCap Advisors first reported a position in DXCM in Q4 2021 and has held it in 12 quarters since. The position peaked at $905K in Q4 2021. 158 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • CoreCap Advisors held 613 shares of DexCom worth $41.3K as of Q2 2026.
  • CoreCap Advisors sold 1 DexCom share in Q2 2026, an estimated $67.
  • DexCom made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1486 holding.
  • CoreCap Advisors first reported a position in DexCom in Q4 2021 and has held it in 12 quarters since.
  • CoreCap Advisors's DexCom position peaked at $905K in Q4 2021.
  • 158 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.